Comparative Analysis of Risk Factors for the Burden of NCDs in Men in European and Asia-Pacific countries (Observational Observations)
Ludmila Radkevich1* and Dariya Radkevich2
1Doctor of Biological Sciences, Chief Researcher, Center for Theoretical Problems of Physicochemical Pharmacology of the Russian Academy of Sciences CTP PCP RAS, Moscow, Russia
2Specialist (Physicist), Analyst, Center for Theoretical Problems of Physicochemical Pharmacology of the Russian Academy of Sciences CTP PCP RAS, Moscow, Russia
*Corresponding Author: Ludmila Radkevich, Doctor of Biological Sciences, Chief Researcher, Center for Theoretical Problems of Physicochemical Pharmacology of the Russian Academy of Sciences CTP PCP RAS, Moscow, Russia.
May 23, 2023; Published:
June 16, 2023
Objective: To study risk factors for the burden of NCD in European and Asia-Pacific countries in 2004.
Methods and results: Mann-Whitney U test.
36 European and 36 Asia-Pacific countries.
The research results showed that in European countries (Group 1) all Global NCD risk factors were statistically significantly (SR) higher than in Asia-Pacific countries (Group 2). Overweight, obesity, hypercholesterolemia, hyperglycemia, hypertension, high consumption of animal products, red meat, animal fats, of animal and total macronutrients and all types of alcoholic beverages was higher in group 1 countries compared to group 2 countries. But the total burden of NCDs in group 1 of CV countries did not differ from group 2.
In group 1 countries, 7 out of 13 cancers, the burden of Alzheimer's disease, Parkinson's disease, multiple sclerosis and suicide were CV in 2-3 times higher than in the 2nd group of countries. This is in line with the idea of NCD risk factors. However, in Group 1 countries, the burden of Type 2 Diabetes, Endocrine Diseases, Depression, Sensory Organ Diseases, Respiratory, Cardiovascular and Digestive Diseases was 1.5-2.5 times lower, which does not correspond to literature data.
Conclusions: Thus, European countries with high NCD risk factors are more successful than Asia-Pacific countries in coping with the burden of NCDs, probably due to high quality of life, health and environmental safety.
Keywords: Quality of Life; Metabolic Syndrome; NCD Risk Factors; Levels of Consumption of Foods; Alcoholic Beverages; Nutrients; Diet Patterns.
- Singh A., et al. “Impact of school policies on non-communicable disease risk factors - a systematic review”. BMC Public Health1 (2017): 292.
- Dugani S and Gaziano TA. “25 by 25: Achieving Global Reduction in Cardiovascular Mortality”. Current Cardiology Reports 1 (2016): 10.
- Ekta G and Tulika MG. “Risk factor distribution for cardiovascular diseases among high school boys and girls of urban Dibrugarh, Assam”. Journal of Family Medicine and Primary Care1 (2016): 108-113.
- Schröders J., et al. “How is Indonesia coping with its epidemic of chronic noncommunicable diseases? A systematic review with meta-analysis”. PLoS One6 (2017): e0179186.
- Sivanantham P., et al. “Profile of risk factors for Non-Communicable Diseases (NCDs) in a highly urbanized district of India: Findings from Puducherry district-wide STEPS Survey, 2019-20”. PLoS One1 (2021): e0245254.
- Singh PN., et al. “Global epidemiology of obesity, vegetarian dietary patterns, and noncommunicable disease in Asian Indians”. The American Journal of Clinical Nutrition 100 (2010): 359S-64S.
- Zhu Z., et al. “A large-scale genome-wide association analysis of lung function in the Chinese population identifies novel loci and highlights shared genetic aetiology with obesity”. European Respiratory Journal 4 (2021): 2100199.
- Ranjani H., et al. “Epidemiology of childhood overweight and obesity in India: A systematic review”. Indian Journal of Medical Research 2 (2016): 160-174.
- Hu CS., et al. “Novel strategies halt cardiovascular, diabetes, and cancer strips”. Chronic Diseases and Translational Medicine 3 (2017): 159-164.
- Akhter N., et al. “Risk factors for non-communicable diseases related to obesity among first- and second-generation Bangladeshi migrants living in north-east or south-east England”. International Journal of Obesity (Lond).7 (2021): 1588-1598.
- Sommer I., et al. “Socioeconomic inequalities in non-communicable diseases and their risk factors: an overview of systematic reviews”. BMC Public Health 15 (2015): 914.
- Norman RE., et al. “Environmental exposures: an underrecognized contribution to noncommunicable diseases”. Reviews on Environmental Health1 (2013): 59-65.
- Vaishali K., et al. “Coping strategies for obese individuals with obstructive sleep apnea during COVID-19 pandemic: A narrative review”. Obesity Medicine 22 (2021): 100324.
- Tan BL., et al. “Nutrients and Oxidative Stress: Friend or Foe?” Oxidative Medicine and Cellular Longevity (2018): 9719584.
- Sahal Estimé M., et al. “Trade as a structural driver of dietary risk factors for noncommunicable diseases in the Pacific: an analysis of household income and expenditure survey data”. Global Health 10 (2014): 48.
- Low WY., et al. “Non-communicable diseases in the Asia-Pacific region: Prevalence, risk factors and community-based prevention”. International Journal of Occupational Medicine and Environmental Health 1 (2015): 20-26.
- Olatona FA., et al. “Dietary habits and metabolic risk factors for non-communicable diseases in a university undergraduate population”. Journal of Health, Population and Nutrition1 (2018): 21.
- Iyengar NM., et al. “Obesity and Cancer Mechanisms: Tumor Microenvironment and Inflammation”. Journal of Clinical Oncology35 (2016): 4270-4276.
- Gallagher EJ and LeRoith D. “Obesity and Diabetes: The Increased Risk of Cancer and Cancer-Related Mortality”. Physiology Review3 (2015): 727-748.
- Wolfe BM., et al. “Treatment of obesity: weight loss and bariatric surgery”. Circulation Research (2016).
- World Health Organization. The global burden of disease: 2004 update (2008).
- United Nations Department of Economic and Social Affairs/Population Division. World Population Prospects (2019).
- Happiness Index HPI 2016 (World Happiness Report 2016). Index of human development (2016).
- 2005-2010. World Population Prospects United Nations. Access to health care, Clean water and Clean air.
- Metabolic syndrome. World Health Organization. 2008. The global burden of disease: 2004 update. Food and Agriculture Organization of the United Nations. Food Balance Sheets 2003-05 (2017).
- Kolb R., et al. “Obesity and cancer: inflammation bridges the two”. Current Opinion in Pharmacology 29 (2016): 77-89.
- Kang C., et al. “Diabetes, Obesity, and Breast Cancer”. Endocrinology11 (2018): 3801-3812.
- Zhang AMY., et al. “Hyperinsulinemia in Obesity, Inflammation, and Cancer”. Diabetes and Metabolism Journal 3 (2021): 285-311.
- Park J., et al. “Obesity and cancer--mechanisms underlying tumour progression and recurrence”. Nature Reviews Endocrinology 8 (2014): 455-465.
- Picon-Ruiz M., et al. “Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention”. CA: A Cancer Journal for Clinicians5 (2017): 378-397.
- Saltiel AR and Olefsky JM. “Inflammatory mechanisms linking obesity and metabolic disease”. Journal of Clinical Investigation 1 (2017): 1-4.
- Powell-Wiley TM., et al. “Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association”.
- St-Onge MP. American Heart Association Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; “Council on Epidemiology and Prevention; and Stroke Council”. Circulation 21 (2021): e984-e1010.
- Gadde KM., et al. “Obesity: Pathophysiology and Management”. Journal of the American College of Cardiology 1 (2018): 69-84.
- Yajnik CS. “Transmission of obesity-adiposity and related disorders from the mother to the baby”. Annals of Nutrition and Metabolism 64 (2014): 8-17.
- Aaron R Keshen., et al. “Effect of stimulant medication on loss of control eating in youth with attention deficit/hyperactivity disorder: a prospective, observational case series study protocol”. Journal of Eating Disorders 1 (2022): 152.